Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers-Reference-Cited by-同舟云学术

Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers

Published:2012-04-15 Issue:5 Volume:59 Page:455-462
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Dooley Kelly E.,Park Jeong-Gun,Swindells Susan,Allen Reena,Haas David W.,Cramer Yoninah,Aweeka Francesca,Wiggins Ilene,Gupta Amita,Lizak Patricia,Qasba Sonia,van Heeswijk Rolf,Flexner Charles

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference24 articles.

1. . Timing of initiation of antiretroviral drugs during tuberculosis therapy.;Abdool Karim;N Engl J Med,2010

2. . Integration of antiretroviral therapy with tuberculosis.;Abdool Karim;N Engl J Med,2011

3. . Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.;Blanc;N Engl J Med,2011

4. . Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.;Havlir;N Engl J Med,2011

5. . Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.;McIlleron;J Infect Dis,2007

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bedaquiline: An Insight Into its Clinical Use in Multidrug-Resistant Pulmonary Tuberculosis;Drug Research;2024-07

2. Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics;Expert Review of Clinical Pharmacology;2024-02-14

3. Acceleration of infectious disease drug discovery and development using a humanized model of drug metabolism;Proceedings of the National Academy of Sciences;2024-02-05

4. Bioanalysis of bedaquiline in human plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study;Journal of Mass Spectrometry and Advances in the Clinical Lab;2024-01

5. QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies;Antimicrobial Agents and Chemotherapy;2023-07-18